Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Neutral
Website
Mach7 Technologies Ltd.Telephone
1.802.861.7745
Address
Suite 210 120 Kimball Avenue South Burlington, VT 05403
Description
Mach7 Technologies Ltd. engages in the development and commercialization of medical imaging and data management software solutions for global healthcare enterprises. It operates through the following geographical segments: North America, Asia Pacific, Middle East, and Europe and Other Regions. The company was founded by Ravi Krishnan in 2007 and is headquartered in South Burlington, VT.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.35 - 0.81
Trade Value (12mth)
AU$30,680.00
1 week
-2.7%
1 month
-32.71%
YTD
-53.25%
1 year
-45.04%
All time high
719.39
EPS 3 yr Growth
-17.00%
EBITDA Margin
-9.70%
Operating Cashflow
$3m
Free Cash Flow Return
6.10%
ROIC
-14.10%
Interest Coverage
-45.90
Quick Ratio
2.20
Shares on Issue (Fully Dilluted)
241m
HALO Sector
Technology
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.16
Date | Announcements |
---|---|
20 November 24 |
Notification of cessation of securities - M7T
×
Notification of cessation of securities - M7T |
20 November 24 |
Change of Director's Interest Notice x 3
×
Change of Director's Interest Notice x 3 |
20 November 24 |
Notification regarding unquoted securities - M7T
×
Notification regarding unquoted securities - M7T |
18 November 24 |
Change in substantial shareholding from AEF
×
Change in substantial shareholding from AEF |
31 October 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
31 October 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 October 24 |
Annual Report to Shareholders FY2024
×
Annual Report to Shareholders FY2024 |
30 October 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
28 October 24 |
Mach7 Signs A$4.3m Licence Expansion And Renewals
×
Mach7 Signs A$4.3m Licence Expansion And Renewals |
24 October 24 |
Wilsons Drug and Device Conference Presentation
×
Wilsons Drug and Device Conference Presentation |
14 October 24 |
Notification of cessation of securities - M7T
×
Notification of cessation of securities - M7T |
11 October 24 |
Notice of Q1 FY25 Result & Investor Webinar
×
Notice of Q1 FY25 Result & Investor Webinar |
03 October 24 |
Date of AGM
×
Date of AGM |
01 October 24 |
Notification of cessation of securities - M7T
×
Notification of cessation of securities - M7T |
01 October 24 |
Change of Director's Interest Notice - ML
×
Change of Director's Interest Notice - ML |
19 September 24 |
Change in Substantial Shareholding from AEF
×
Change in Substantial Shareholding from AEF |
28 August 24 |
Preliminary Final Report and Audited Financial Statements
×
Preliminary Final Report and Audited Financial Statements |
28 August 24 |
FY24 Results Highlights
×
FY24 Results Highlights |
28 August 24 |
Investor Presentation FY2024 Results
×
Investor Presentation FY2024 Results |
15 August 24 |
Amendment to Appendix 3Y - ES
×
Amendment to Appendix 3Y - ES |
30 July 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
22 July 24 |
Notification of cessation of securities - M7T
×
Notification of cessation of securities - M7T |
11 July 24 |
Notice of FY24 Result & Investor Webinar
×
Notice of FY24 Result & Investor Webinar |
10 July 24 |
Notice of Q4 FY24 Result & Investor Webinar
×
Notice of Q4 FY24 Result & Investor Webinar |
28 June 24 |
Notification of cessation of securities - M7T
×
Notification of cessation of securities - M7T |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.